Administrative Core
Administrative Core
批准号:
10415965
负责人:
Scott Kopetz
金额:
$26.82万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-20 至 2024-05-31
关键词:
AddressAdherenceAdministratorAdvocateAwarenessBioinformaticsBiometryBudgetsCancer CenterCancer Center Support GrantCancer PatientCatchment AreaCenter Core GrantsClinicalClinical TrialsCollaborationsColorectal CancerCommunicationCommunitiesConsultConsultationsCountryCountyData LinkagesDecision MakingDepositionDevelopmentEnsureEnvironmentExpenditureExtramural ActivitiesFundingGoalsGrantHuman ResourcesInfrastructureInstitutionJointsLeadershipMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMalignant neoplasm of pancreasManuscriptsMedical centerMinorityMissionMonitorPathologyPatient advocacyPatientsPreparationProgress ReportsQuality ControlRegulationReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsSamplingSiteSystemTexasTimeTranslatingTranslational ResearchUnderrepresented MinorityUniversitiesWomananticancer researchcareerdata accessdata exchangedata integrationdata integritydata qualitydata sharingdesignexperiencemedically underservedmeetingsminority communitiesmultidisciplinaryoperationprogramsquality assurancetranslational research programunderserved community
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ADMINISTRATIVE CORE: Abstract/Summary
The Administrative Core (AC) will provide all of the administrative and budgetary support to the MD Anderson
Cancer Center Cancer SPORE in Gastrointestinal Cancers PIs and investigators, and form the central “hub” for
productive interactions within the SPORE community. It is co-directed by Drs. Scott Kopetz and Anirban Maitra,
and supported by a research program manager, Dr. David Menter, an experienced multi-investigator grant
administrator and investigator. Both, Dr Kopetz and Dr. Maitra have experience in overseeing multi-investigator
grants that include Institutional Grants, Cancer Center Core Grant Programs, and Stand Up to Cancer Grants.
The overall goal of the AC will be coordination and monitoring of 3 Projects, 2 additional Cores, as well as the
Developmental Research (DRP) and Career Enhancement (CEP) Programs. The AC is designed to monitor
research activity and provide stable and continuous leadership and direction that advances integration,
communication, and collaboration among GI SPORE investigators within MD Anderson and among extramural
institutions, in particular, our partner institution, Johns Hopkins University (JHU). The AC will leverage the wideranging scientific, research, and SPORE-related experience of both Internal and External Advisory Boards in
critical decision-making steps. The AC will ensure fiscal management, including personnel, budgets, and effort
oversight, facilitate communication, interfacing with patient advocates, organization of meetings, manuscript
preparation, and progress and other reports to the NCI and GI SPORE committees, and cross-communication
of Cores and Programs. Of paramount importance is to ensure timely communication and consultation with the
NCI Translational Research Program Director and staff for both adherence and deviations from stated
programmatic goals. This Core is to also monitor scientific integrity and overall compliance with all institutional,
state, federal, and NCI regulations and requirements, as well as quality assurance for data integrity including a
change in the data integration plan with utilization of the new institutional clinical trial management system
(CTMS) in lieu of Redcap, which provides greater data linkage residing in the Biospecimen and Pathology
Core (Core 1) and Biostatistics and Bioinformatics Core (Core 2). The AC will be responsible for oversight of
DRP and CEP for completion of deliverables. The AC also facilitates routine convening of staff and management
of all necessary meetings. The AC will also enhanced awareness of colorectal and pancreatic cancer research
and patient advocacy in the community as well as ongoing needs of minority and underserved communities in
Houston and Harris County catchment area. This core will also help leverage and facilitate translational GI
cancer research efforts being conducted by extramural groups locally and in the US and globally through both
horizontal and vertical collaborations within the SPORE framework.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MDACC-PREDICT
-
批准号:10266195
-
项目类别:
-
资助金额:$67.05万
-
财政年份:2020
-
负责人:Scott Kopetz
-
依托单位:
MDACC-PREDICT
-
批准号:10253153
-
项目类别:
-
资助金额:$66.99万
-
财政年份:2020
-
负责人:Scott Kopetz
-
依托单位:
Career Enhancement Program
-
批准号:10415973
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2019
-
负责人:Scott Kopetz
-
依托单位:
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
-
批准号:10226083
-
项目类别:
-
资助金额:$198.74万
-
财政年份:2019
-
负责人:Scott Kopetz
-
依托单位:
Administrative Core
-
批准号:10226084
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2019
-
负责人:Scott Kopetz
-
依托单位:
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
-
批准号:10415964
-
项目类别:
-
资助金额:$221.13万
-
财政年份:2019
-
负责人:Scott Kopetz
-
依托单位:
Career Enhancement Program
-
批准号:10226092
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2019
-
负责人:Scott Kopetz
-
依托单位:
Colorectal Cancer Molecular Subtype Assay Development and Validation
-
批准号:10463838
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2018
-
负责人:Scott Kopetz
-
依托单位:
Colorectal Cancer Molecular Subtype Assay Development and Validation
-
批准号:9789655
-
项目类别:
-
资助金额:$16.37万
-
财政年份:2018
-
负责人:Scott Kopetz
-
依托单位:
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
-
批准号:10439595
-
项目类别:
-
资助金额:$65.07万
-
财政年份:2018
-
负责人:Scott Kopetz
-
依托单位:
Colorectal Cancer Molecular Subtype Assay Development and Validation
-
批准号:10334569
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2018
-
负责人:Scott Kopetz
-
依托单位:
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
-
批准号:10197832
-
项目类别:
-
资助金额:$66.4万
-
财政年份:2018
-
负责人:Scott Kopetz
-
依托单位:
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
-
批准号:10242651
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Scott Kopetz
-
依托单位:
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
-
批准号:10681975
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2017
-
负责人:Scott Kopetz
-
依托单位:
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
-
批准号:10242643
-
项目类别:
-
资助金额:$21.81万
-
财政年份:2017
-
负责人:Scott Kopetz
-
依托单位:
Stress Signaling Pathways and Resistance in Colorectal Cancer
-
批准号:8420658
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2013
-
负责人:Scott Kopetz
-
依托单位:
Stress Signaling Pathways and Resistance in Colorectal Cancer
-
批准号:8606445
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2013
-
负责人:Scott Kopetz
-
依托单位:
Src inhibition in Colorectal Cancer
-
批准号:7570789
-
项目类别:
-
资助金额:$13.48万
-
财政年份:2008
-
负责人:Scott Kopetz
-
依托单位:
Src inhibition in Colorectal Cancer
-
批准号:7694304
-
项目类别:
-
资助金额:$13.48万
-
财政年份:2008
-
负责人:Scott Kopetz
-
依托单位:
Src inhibition in Colorectal Cancer
-
批准号:8123384
-
项目类别:
-
资助金额:$13.48万
-
财政年份:2008
-
负责人:Scott Kopetz
-
依托单位:
海外基金